DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment

First published 22/04/2024

Last updated 23/06/2025

EU PAS number:

EUPAS1000000112

Study

Ongoing

Documents

Study protocol

Initial protocol

DARWIN EU_D2.2.3_Protocol_P2-C3-003_NSCLC_v3.2_Clean.pdf

English (884.56 KB - PDF)View document

Updated protocol

DARWIN EU_Protocol_P2-C3-003_NSCLC_V5_Amendment.pdf

First published: 17/09/2024

English (1014.16 KB - PDF)View document

Study results

Study report

DARWIN EU_Final Report_P2-C3-003_NSCLC_V5.pdf

English (2.84 MB - PDF)View document

Other information

Secondary tabs